Amedeo Smart

Free Medical Literature Service


 

Amedeo

Irritable Bowel Syndrome

  Free Subscription

Articles published in
Eur J Gastroenterol Hepatol
    November 2023
  1. WANG YN, Zhou LY, Huang YH, Jiang M, et al
    The incidence and predisposing factors for irritable bowel syndrome following COVID-19: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2023 Nov 30. doi: 10.1097/MEG.0000000000002688.
    >> Share

    April 2023
  2. YAMAMOTO Y, Furukawa S, Miyake T, Watanabe J, et al
    Exercise habits that include exercise partners and irritable bowel syndrome in a young Japanese population: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2023 Apr 17. doi: 10.1097/MEG.0000000000002561.
    >> Share

    January 2023
  3. ROKKAS T, Hold GL
    A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome.
    Eur J Gastroenterol Hepatol. 2023 Jan 31. doi: 10.1097/MEG.0000000000002519.
    >> Share

  4. SIYAL M, Abbas Z, Ashraf J, Ali Qadeer M, et al
    Incidence and predisposing factors for de novo post-COVID-19 irritable bowel syndrome.
    Eur J Gastroenterol Hepatol. 2023;35:59-63.
    >> Share

    September 2022
  5. CHENG F, Fan Z, Lin C, Zhu Y, et al
    Effect of altered gut microbiota on visceral hypersensitivity of postinfectious irritable bowel syndrome mice.
    Eur J Gastroenterol Hepatol. 2022 Sep 12. pii: 00042737-990000000-00069.
    >> Share

    March 2022
  6. HASSANIN TM, Fouad Y, Mohamed FE, Abdel-Hafeez EH, et al
    Colonic mucosal eosinophilia and immunohistochemical expression of COX-2 and NF-kB in patients with irritable bowel syndrome.
    Eur J Gastroenterol Hepatol. 2022 Mar 10. pii: 00042737-900000000-97082.
    >> Share

    February 2022
  7. HURYCH J, Vodolanova L, Vejmelka J, Drevinek P, et al
    Freezing of faeces dramatically decreases the viability of Blastocystis sp. and Dientamoeba fragilis.
    Eur J Gastroenterol Hepatol. 2022;34:242-243.
    >> Share

    November 2021
  8. KRAMER S, Masclee AAM, Jebbink RJA, Tack GJ, et al
    Commonly used biomarkers do not contribute to diagnosing irritable bowel syndrome.
    Eur J Gastroenterol Hepatol. 2021 Nov 12. pii: 00042737-900000000-97124.
    >> Share

    July 2021
  9. DEUTSCH D, Bouchoucha M, Devroede G, Raynaud JJ, et al
    Functional gastrointestinal disorders as predictors of suicidal ideation. An observational study.
    Eur J Gastroenterol Hepatol. 2021 Jul 6. pii: 00042737-900000000-97181.
    >> Share

    June 2021
  10. JONES MP, Walter S, Talley NJ, Walker MM, et al
    Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes.
    Eur J Gastroenterol Hepatol. 2021 Jun 17. pii: 00042737-900000000-97188.
    >> Share

    April 2021
  11. TURSI A, Elisei W, Franceschi M, Picchio M, et al
    The prevalence of symptomatic uncomplicated diverticular disease could be lower than expected: a single-center colonoscopy-based cohort study.
    Eur J Gastroenterol Hepatol. 2021 Apr 16. pii: 00042737-900000000-97250.
    >> Share

    January 2021
  12. WONGTRAKUL W, Charoenngam N, Ungprasert P
    Increased prevalence of irritable bowel syndrome in migraine patients: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2021 Jan 18. pii: 00042737-900000000-97319.
    >> Share

  13. SCHINDLER V, Hente J, Murray FR, Hullner M, et al
    Adding a liquid test meal to a standardized lactulose hydrogen breath test significantly influences abdominal symptom generation and hydrogen values.
    Eur J Gastroenterol Hepatol. 2021 Jan 14. pii: 00042737-900000000-97326.
    >> Share

    November 2020
  14. LYUTAKOV I, Lozanov V, Sugareva P, Valkov H, et al
    Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2020 Nov 10. doi: 10.1097/MEG.0000000000001925.
    >> Share

    September 2020
  15. REICHER-ATIR R, Avnat-Becker L, Levy S, Sperber AD, et al
    Psychological defense mechanisms and use of corporeal discourse: a comparison between patients with irritable bowel syndrome, medical personnel and healthy volunteers.
    Eur J Gastroenterol Hepatol. 2020 Sep 17. doi: 10.1097/MEG.0000000000001940.
    >> Share

    April 2020
  16. WANG J, Wang Y, Zhou H, Gu W, et al
    Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea.
    Eur J Gastroenterol Hepatol. 2020 Apr 20. doi: 10.1097/MEG.0000000000001737.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016